CARL R GRAY M.D. NPI 1598873382

NPI Information

  • NPI: 1598873382
  • Provider Name: CARL R GRAY, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5405 S 500 E STE 202
    OGDEN, UT
    ZIP 84405
  • Phone: (801) 476-1777

Map and Directions

Get Directions

NPI Details

Carl R Gray, M.D. is a hematology and oncology internal medicine in Ogden, UT with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Carl R Gray, M.D. NPI is 1598873382. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:1995

The provider's business location address is:

5405 S 500 E STE 202
OGDEN, UT
ZIP 84405-419
Phone: (801) 476-1777
Fax: (801) 479-1479

The NPI 1598873382 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, romiplostim, 10 micrograms (HCPCS:J2796)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Magnesium level (HCPCS:83735)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of prolonged chemotherapy into vein (HCPCS:96416)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Blood test, clotting time (HCPCS:85610)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Folic acid level, serum (HCPCS:82746)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Vitamin d-3 level (HCPCS:82306)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)

The enumeration date for this NPI number is 8/29/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology5553369-1205UTAHYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
10105599703MEDICARE ID-TYPE UNSPECIFIED
2G69475MEDICARE UPIN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.